Indications for minimally invasive surgery for ovarian cancer

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 9, Issue 1, 2011, Pages 126-132

  Han, Ernest S ^a   Wakabayashi, Mark ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Laparoscopy; Minimally invasive surgery; Ovarian cancer

Indexed keywords

ADNEXA DISEASE; ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CYTOREDUCTIVE SURGERY; DISEASE SEVERITY; EARLY CANCER; HUMAN; LAPAROSCOPIC SURGERY; LAPAROSCOPY; LAPAROTOMY; MINIMALLY INVASIVE SURGERY; OVARY CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT CANCER; REVIEW; SECOND LOOK SURGERY;

EID: 78951482856     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2011.0011     Document Type: Review

References (46)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:1-24.
2. Fleming GF, Ronnett BM, Seidman J, et al., eds. Principles and Practice of Gynecologic Oncology. Philadelphia: Lippincott Williams & Wilkins; 2009:763-835.
3. Morgan RJ, Alvarez RD, Armstrong DK, et al. NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer. Version 1, 2011. Available at: http://www.nccn.org/professionals/physician-gls/PDF/ovarian.pdf. Accessed November 11, 2010.
4. Young RC, Decker DG, Wharton JT, et al. Staging laparotomy in early ovarian cancer. JAMA 1983;250:3072-3076.
5. Walker JL, Piedmonte MR, Spirtos NM, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group study LAP2. J Clin Oncol 2009;27:5331-5336.
6. Ramirez PT, Soliman PT, Schmeler KM, et al. Laparoscopic and robotic techniques for radical hysterectomy in patients with early-stage cervical cancer. Gynecol Oncol 2008;110:S21-24.
7. Trimbos JB, Vergote I, Bolis G, et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer - adjuvant chemotherapy in ovarian neoplasm trial. J Natl Cancer Inst 2003;95:113-125.
8. Trimbos JB, Parmar M, Vergote I, et al. International collaborative ovarian neoplasm trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003;95:105-112. (Pubitemid 36196730)
9. Querleu D, LeBlanc E. Laparoscopic infrarenal paraaortic lymph node dissection for restaging of carcinoma of the ovary or fallopian tube. Cancer 1994;73:1467-1471.
10. Childers JM, Lang J, Surwit EA, Hatch KD. Laparoscopic surgical staging of ovarian cancer. Gynecol Oncol 1995;59:25-33.
11. Pomel C, Provencher D, Dauplat J, et al. Laparoscopic staging of early ovarian cancer. Gynecol Oncol 1995;58:301-306.
12. Tozzi R, Kohler C, Ferrara A, Schneider A. Laparoscopic treatment of early ovarian cancer: surgical and survival outcomes. Gynecol Oncol 2004;93:199-203.
13. Leblanc E, Querleu D, Narducci F, et al. Laparoscopic restaging of early invasive adnexal tumors: a 10-year experience. Gynecol Oncol 2004;94:624-629. (Pubitemid 39194452)
14. Spirtos NM, Eisekop SM, Boike G, et al. Laparoscopic staging in patients with incompletely staged cancers of the uterus, ovary, fallopian tube, and primary peritoneum: a Gynecologic Oncology Group (GOG) study. Am J Obstet Gynecol 2005;193:1645-1649.
15. Colomer AT, Jimenez AM, Barcelo IB. Laparoscopic treatment and staging of early ovarian cancer. J Minim Invasive Gynecol 2008;15:414-419.
16. Jung US, Lee JH, Kyung MS, Choi JS. Feasibility and efficacy of laparoscopic management of ovarian cancer. J Obstet Gynaecol Res 2009;35:113-118.
17. Nezhat FR, Ezzati M, Chuang L, et al. Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome. Am J Obstet Gynecol 2009;200:83.e1-83.e6.
18. Ghezzi F, Cromi A, Siesto G, et al. Laparoscopy staging of early ovarian cancer. Int J Gynecol Cancer 2009;19:S7-13.
19. Chi DS, Abu-Rustum NR, Sonoda Y, et al. The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers. Am J Obstet Gynecol 2005;192:1614-1619.
20. Lecuru F, Desfeux P, Camatte S, et al. Impact of initial surgical access on staging and survival of patients with stage I ovarian cancer. Int J Gynecol Cancer 2006;16:87-94.
21. Ghezzi F, Cromi A, Uccella S, et al. Laparoscopy versus laparotomy for the surgical management of apparent early stage ovarian cancer. Gynecol Oncol 2007;105:409-413. (Pubitemid 46590334)
22. Park JY, Bae J, Lim MC, et al. Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety. Int J Gynecol Cancer 2008;18:1202-1209.
23. Park JY, Kim DY, Suh DS, et al. Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer. Ann Surg Oncol 2008;15:2012-2019.
24. Abu-Rustum NR, Rhee EH, Chi DS, et al. Subcutaneous tumor implantation after laparoscopic procedures in women with malignant disease. Obstet Gynecol 2004;103:480-487.
25. Ramirez PT, Frumovitz M, Wolf JK, Levenback C. Laparoscopic port-site metastases in patients with gynecologic malignancies. Int J Gynecol Cancer 2004;14:1070-1077. (Pubitemid 39603349)
26. Vergote I, Marquette S, Amant F, et al. Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma. Int J Gynecol Cancer 2005;15:776-779.
27. Zivanovic O, Sonoda Y, Diaz JP, et al. The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease. Gynecol Oncol 2008;111:431-437.
28. Vergote I, De Brabanter J, Fyles A, et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001;357:176-182.
29. Bakkum-Gamez JN, Richardson DL, Seamon LG, et al. Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer. Obstet Gynecol 2009;113:11-17.
30. Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002;20:1248-1259.
31. Hoskins WJ, McGuire WP, Brady MF, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994;170:974-979.
32. Angioli R, Palaia I, Zullo MA, et al. Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecol Oncol 2006;100:455-461. (Pubitemid 43246859)
33. Deffieux X, Castaigne D, Pomel C. Role of laparoscopy to evaluate candidates for complete cytoreduction in advanced stages of epithelial ovarian cancer. Int J Gynecol Cancer 2006;16(Suppl 1):35-40.
34. Fagotti A, Ferrandina G, Fanfani F, et al. A laparoscopic-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol 2006;13:1156-1161.
35. Brun JL, Rouzier R, Uzan S, Darai E. External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. Gynecol Oncol 2008;110:354-359.
36. Fagotti A, Ferrandina G, Fanfani F, et al. Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. Am J Obstet Gynecol 2008;199:642.e1-642.e6.
37. Chereau E, Ballester M, Selle F, et al. Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer. Am J Obstet Gynecol 2010;202:178.e1-178.e10.
38. Bristow RE. Predicting "unresectable" ovarian cancer: taking aim at a moving target. Gyncol Oncol 2006;100:449-450.
39. Fanning J, Hojat R, Johnson J, Fenton B. Laparoscopic cytoreduction for primary advanced ovarian cancer. JSLS 2010;14:80-82.
40. Krivak TC, Elkas JC, Rose GS, et al. The utility of hand-assisted laparoscopy in ovarian cancer. Gynecol Oncol 2005;96:72-76.
41. Ozols RF, Bundy BN, Greer BE, et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 2003;21:3194-3200.
42. Husain A, Chi DS, Prasad M, et al. The role of laparoscopy in second-look evaluations for ovarian cancer. Gynecol Oncol 2001;80:44-47.
43. Littell RD, Hallonquist H, Matulonis U, et al. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma. Gynecol Oncol 2006;103:570-574.
44. Chi DS, Abu-Rustum NR, Sonoda Y, et al. Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer. Gynecol Oncol 2006;101:224-227.
45. Otrock ZK, Seoud MA, Khalifeh MJ, et al. Laparoscopic splenectomy for isolated parenchymal splenic metastasis of ovarian cancer. Int J Gynecol Cancer 2006;16:1933-1935.
46. Trinh H, Ott C, Fanning J. Feasibility of laparoscopic debulking with electrosurgical loop excision procedure and argon beam coagulator at recurrence in patients with previous laparotomy debulking. Am J Obstet Gynecol 2004;190:1394-1397. (Pubitemid 38692226)